Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Venous Thromboembolism in Viral Diseases: A Comprehensive Literature Review Publisher



Zerangian N1 ; Erabi G2 ; Poudineh M3 ; Monajjem K4 ; Diyanati M5 ; Khanlari M4 ; Khalaji A6 ; Allafi D2 ; Faridzadeh A7, 8 ; Amali A9 ; Alizadeh N10 ; Salimi Y11 ; Ghane Ezabadi S12 ; Abdi A13 Show All Authors
Authors
  1. Zerangian N1
  2. Erabi G2
  3. Poudineh M3
  4. Monajjem K4
  5. Diyanati M5
  6. Khanlari M4
  7. Khalaji A6
  8. Allafi D2
  9. Faridzadeh A7, 8
  10. Amali A9
  11. Alizadeh N10
  12. Salimi Y11
  13. Ghane Ezabadi S12
  14. Abdi A13
  15. Hasanabadi Z14
  16. Shojaeibaghini M15
  17. Deravi N16
Show Affiliations
Authors Affiliations
  1. 1. Health Education and Health Promotion, Department of Health Education and Health Promotion, School of Health, Mashhad University of Medical Sciences, Mashhad, Iran
  2. 2. Student Research Committee, Urmia University of Medical Sciences, Urmia, Iran
  3. 3. School of Medicine, Zanjan University of Medical Sciences, Zanjan, Iran
  4. 4. Student Research Committee, Tabriz University of Medical Sciences, Tabriz, Iran
  5. 5. Student Research Committee, Rafsanjan University of Medical Sciences, Rafsanjan, Iran
  6. 6. School of Medicine, Tehran University of Medical Sciences, Tehran, Iran
  7. 7. Department of Immunology and Allergy, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran
  8. 8. Immunology Research Center, Mashhad University of Medical Sciences, Mashhad, Iran
  9. 9. Student Research Committee, Paramedical Department, Islamic Azad University, Mashhad Branch, Mashhad, Iran
  10. 10. Doctor of Medicine (MD), School of Medicine, Iran University of Medical Sciences, Tehran, Iran
  11. 11. Student Research Committee, Kermanshah University of Medical Sciences, Kermanshah, Iran
  12. 12. Student's Scientific Research Center, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran
  13. 13. Student Research Committee, School of Medicine, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran
  14. 14. Doctor of Medicine (MD), School of Medicine, Qazvin University of Medical Science, Qazvin, Iran
  15. 15. Medical Informatics Research Center, Institute for Futures Studies in Health, Kerman University of Medical Sciences, Kerman, Iran
  16. 16. Student Research Committee, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran

Source: Health Science Reports Published:2023


Abstract

Venous thromboembolism (VTE) is known to be a common respiratory and/or cardiovascular complication in hospitalized patients with viral infections. Numerous studies have proven human immunodeficiency virus infection to be a prothrombotic condition. An elevated VTE risk has been observed in critically ill H1N1 influenza patients. VTE risk is remarkably higher in patients infected with the Hepatitis C virus in contrast to uninfected subjects. The elevation of D-dimer levels supported the association between Chikungunya and the Zika virus and the rise of clinical VTE risk. Varicella-zoster virus is a risk factor for both cellulitis and the consequent invasive bacterial disease which may take part in thrombotic initiation. Eventually, hospitalized patients infected with the coronavirus disease of 2019 (COVID-19), the cause of the ongoing worldwide pandemic, could mainly suffer from an anomalous risk of coagulation activation with enhanced venous thrombosis events and poor quality clinical course. Although the risk of VTE in nonhospitalized COVID-19 patients is not known yet, there are a large number of guidelines and studies on thromboprophylaxis administration for COVID-19 cases. This study aims to take a detailed look at the effect of viral diseases on VTE, the epidemiology of VTE in viral diseases, and the diagnosis and treatment of VTE. © 2023 The Authors. Health Science Reports published by Wiley Periodicals LLC.
Related Docs
View other Related Docs
1. Coagulopathy and Thromboembolic Events a Pathogenic Mechanism of Covid-19 Associated With Mortality: An Updated Review, Journal of Clinical Laboratory Analysis (2023)
2. Pathological Effects of Sars-Cov-2 on Hematological and Immunological Cells: Alterations in Count, Morphology, and Function, Pathology Research and Practice (2022)
3. Covid-19 Infection and Stroke Risk, Reviews in the Neurosciences (2021)
4. Thrombotic Storm in Coronavirus Disease 2019: From Underlying Mechanisms to Its Management, Journal of Medical Microbiology (2022)
5. Anticoagulant Therapy in Covid-19: A Narrative Review, Clinical and Translational Science (2023)
6. Coagulopathy: Another Side Effect of Coronavirus Infection, Journal of Cardiovascular and Thoracic Research (2021)
7. Covid-19 and Multiorgan Failure: A Narrative Review on Potential Mechanisms, Journal of Molecular Histology (2020)
8. Dysregulated Mirnas Network in the Critical Covid-19: An Important Clue for Uncontrolled Immunothrombosis/Thromboinflammation, International Immunopharmacology (2022)
Experts (# of related papers)
View all Related Experts
Nima Rezaei (38)
Azita Hajhossein Talasaz (13)
Other Related Docs
9. Comprehensive Review of Cardiovascular Complications of Coronavirus Disease 2019 and Beneficial Treatments, Cardiology in Review (2022)
10. Cardiovascular Diseases Burden in Covid-19: Systematic Review and Meta-Analysis, American Journal of Emergency Medicine (2021)
11. Complement Inhibition: A Possible Therapeutic Approach in the Fight Against Covid-19, Reviews in Medical Virology (2022)
12. Pharmacotherapy Consideration of Thrombolytic Medications in Covid-19-Associated Ards, Journal of Intensive Care (2022)
13. Corona Virus Disease 2019 (Covid-19) As a System-Level Infectious Disease With Distinct Sex Disparities, Frontiers in Immunology (2021)
14. Post-Discharge Thromboembolic Events in Covid-19 Patients: A Review on the Necessity for Prophylaxis, Clinical and Applied Thrombosis/Hemostasis (2023)
15. Biomarker Based Biosensors: An Opportunity for Diagnosis of Covid-19, Reviews in Medical Virology (2022)
16. Diabetes As One of the Long-Term Covid-19 Complications: From the Potential Reason of More Diabetic Patients’ Susceptibility to Covid-19 to the Possible Caution of Future Global Diabetes Tsunami, Inflammopharmacology (2023)
17. Covid-19-Associated Pulmonary Embolism: Review of the Pathophysiology, Epidemiology, Prevention, Diagnosis, and Treatment, Seminars in Thrombosis and Hemostasis (2023)
18. Pharmacotherapy for Prevention and Management of Thrombosis in Covid-19, Seminars in Thrombosis and Hemostasis (2020)
19. Pathogenesis, Clinical Manifestations and Complications of Coronavirus Disease 2019 (Covid-19), Future Microbiology (2020)
20. Recent Randomized Trials of Antithrombotic Therapy for Patients With Covid-19: Jacc State-Of-The-Art Review, Journal of the American College of Cardiology (2021)
21. Molecular Signaling Pathways, Pathophysiological Features in Various Organs, and Treatment Strategies in Sars-Cov2 Infection, Acta Histochemica (2022)
22. Sars-Cov-2: Current Trends in Emerging Variants, Pathogenesis, Immune Responses, Potential Therapeutic, and Vaccine Development Strategies, International Immunopharmacology (2021)
23. Renal, Cardiac, Neurological, Cutaneous and Coagulopathic Long-Term Manifestations of Covid-19 After Recovery; a Review, Epidemiology and Infection (2022)
24. Cardiovascular Disease in Covid-19: A Systematic Review and Meta-Analysis of 10,898 Patients and Proposal of a Triage Risk Stratification Tool, Egyptian Heart Journal (2020)
25. Cardiovascular Complications of Covid-19: Pharmacotherapy Perspective, Cardiovascular Drugs and Therapy (2021)
26. Evaluation of Blood Biochemistry and Cardiopulmonary Status of Hospitalized Covid-19 Patients in 3 Months Post Discharged Follow up Survey, Clinical Medicine Insights: Circulatory# Respiratory and Pulmonary Medicine (2022)
27. A Review on Currently Available Potential Therapeutic Options for Covid-19, International Journal of General Medicine (2020)
28. Immune Profiling of Sars-Cov-2; What We Know and What We Don’T Know, Iranian Journal of Allergy# Asthma and Immunology (2023)
29. Sars-Cov-2 and Acute Cerebrovascular Events: An Overview, Journal of Clinical Medicine (2021)
30. Ischemic Gastrointestinal Complications of Covid-19: A Systematic Review on Imaging Presentation, Clinical Imaging (2021)
31. Recent Findings on the Coronavirus Disease 2019 (Covid-19); Immunopathogenesis and Immunotherapeutics, International Immunopharmacology (2020)
32. Immunoediting in Sars-Cov-2: Mutual Relationship Between the Virus and the Host, International Immunopharmacology (2022)
33. Multi-Facets of Neutrophil Extracellular Trap in Infectious Diseases: Moving Beyond Immunity, Microbial Pathogenesis (2021)
34. Covid-19’S Immuno-Pathology and Cardiovascular Diseases, Journal of Investigative Medicine (2023)
35. Immunopathological Similarities Between Covid-19 and Influenza: Investigating the Consequences of Co-Infection, Microbial Pathogenesis (2021)
36. Cardiovascular Implications of the Covid-19: Management of Complications and Drug Safety Concerns, Journal of Research in Medical Sciences (2022)
37. Risk Factors for Adverse Outcomes of Covid-19 Patients: Possible Basis for Diverse Responses to the Novel Coronavirus Sars-Cov-2, Life Sciences (2021)
38. Critical Complications of Covid-19: A Descriptive Meta-Analysis Study, Reviews in Cardiovascular Medicine (2020)
39. Cardiac Injury Is Associated With Severe Outcome and Death in Patients With Coronavirus Disease 2019 (Covid-19) Infection: A Systematic Review and Meta-Analysis of Observational Studies, European Heart Journal: Acute Cardiovascular Care (2020)
40. Risk of Stroke in Hospitalized Sars-Cov-2 Infected Patients: A Multinational Study, EBioMedicine (2020)
41. Covid-19 and Varicocele: The Possible Overlap Factors and the Common Therapeutic Approaches, American Journal of Reproductive Immunology (2022)
42. A Comprehensive Review on Covid-19 Infection and Comorbidities of Various Organs, Acta Medica Iranica (2021)
43. Histopathologic Changes and Cellular Events of Organs Systems in Covid-19, Journal of Cellular and Molecular Anesthesia (2021)
44. Pathologic Features of Covid-19: A Concise Review, Pathology Research and Practice (2020)
45. Factors Associated With Covid-19 Morbidity and Mortality: A Narrative Review, Journal of Iranian Medical Council (2020)
46. Immunomodulatory-Based Therapy As a Potential Promising Treatment Strategy Against Severe Covid-19 Patients: A Systematic Review, International Immunopharmacology (2020)
47. The Contributory Role of Lymphocyte Subsets, Pathophysiology of Lymphopenia and Its Implication As Prognostic and Therapeutic Opportunity in Covid-19, International Immunopharmacology (2021)
48. The Risk Factors and Clinical Outcomes Associated With Acute Kidney Injury in Patients With Covid-19: Data From a Large Cohort in Iran, Kidney and Blood Pressure Research (2021)
49. Intermediate Versus Standard-Dose Prophylactic Anticoagulation and Statin Therapy Versus Placebo in Critically-Ill Patients With Covid-19: Rationale and Design of the Inspiration/Inspiration-S Studies, Thrombosis Research (2020)
50. Immunosenescence and Inflamm-Ageing in Covid-19, Ageing Research Reviews (2023)